Literature DB >> 33355322

Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics.

Kalyani Desale1, Kaushik Kuche1, Sanyog Jain1.   

Abstract

In the field of nanotherapeutics, gaining cellular entry into the cytoplasm of the target cell continues to be an ultimate challenge. There are many physicochemical factors such as charge, size and molecular weight of the molecules and delivery vehicles, which restrict their cellular entry. Hence, to dodge such situations, a class of short peptides called cell-penetrating peptides (CPPs) was brought into use. CPPs can effectively interact with the cell membrane and can assist in achieving the desired intracellular entry. Such strategy is majorly employed in the field of cancer therapy and diagnosis, but now it is also used for other purposes such as evaluation of atherosclerotic plaques, determination of thrombin levels and HIV therapy. Thus, the current review expounds on each of these mentioned aspects. Further, the review briefly summarizes the basic know-how of CPPs, their utility as therapeutic molecules, their use in cancer therapy, tumor imaging and their assistance to nanocarriers in improving their membrane penetrability. The review also discusses the challenges faced with CPPs pertaining to their stability and also mentions the strategies to overcome them. Thus, in a nutshell, this review will assist in understanding how CPPs can present novel possibilities for resolving the conventional issues faced with the present-day nanotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33355322     DOI: 10.1039/d0bm01755h

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  7 in total

1.  Peptide Permeation across a Phosphocholine Membrane: An Atomically Detailed Mechanism Determined through Simulations and Supported by Experimentation.

Authors:  Alfredo E Cardenas; Chad I Drexler; Rachel Nechushtai; Ron Mittler; Assaf Friedler; Lauren J Webb; Ron Elber
Journal:  J Phys Chem B       Date:  2022-04-07       Impact factor: 3.466

2.  In silico identification and experimental validation of cellular uptake and intracellular labeling by a new cell penetrating peptide derived from CDN1.

Authors:  Xiangli Guo; Linlin Chen; Lidan Wang; Jingping Geng; Tao Wang; Jixiong Hu; Jason Li; Changbai Liu; Hu Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

3.  GRP75-driven, cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+ nanoparticles underlies distinct gene therapy effect in ovarian cancer.

Authors:  Linjia Su; Zhe Sun; Fangzheng Qi; Huishan Su; Luomeng Qian; Jing Li; Liang Zuo; Jinhai Huang; Zhilin Yu; Jinping Li; Zhinan Chen; Sihe Zhang
Journal:  J Nanobiotechnology       Date:  2022-07-20       Impact factor: 9.429

Review 4.  AIEgen-Peptide Bioprobes for the Imaging of Organelles.

Authors:  Bochao Chen; Haotong Yuan; Wei Zhang; Jingjing Hu; Xiaoding Lou; Fan Xia
Journal:  Biosensors (Basel)       Date:  2022-08-22

5.  Cyclic Peptoid-Peptide Hybrids as Versatile Molecular Transporters.

Authors:  Claudine Nicole Herlan; Anna Meschkov; Ute Schepers; Stefan Bräse
Journal:  Front Chem       Date:  2021-06-25       Impact factor: 5.221

Review 6.  Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery.

Authors:  Prisca Boisguérin; Karidia Konate; Emilie Josse; Eric Vivès; Sébastien Deshayes
Journal:  Biomedicines       Date:  2021-05-20

Review 7.  The Peptide Functionalized Inorganic Nanoparticles for Cancer-Related Bioanalytical and Biomedical Applications.

Authors:  Xiaotong Li; Minghong Jian; Yanhong Sun; Qunyan Zhu; Zhenxin Wang
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.